AbbVie to Acquire Aliada Therapeutics for $1.4 Billion, Advancing Alzheimer's Research

AbbVie (NYSE: ABBV) and Aliada Therapeutics announced a definitive agreement under which AbbVie will acquire Aliada, a biotechnology company advancing...

October 29, 2024 | Tuesday | News
Samsung Biologics Secures Landmark $1.24 Billion Contract with Asia-Based Pharma

INCHEON, South Korea, Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced a contra...

October 22, 2024 | Tuesday | News
Sanofi Moves Toward Strategic Divestment, Negotiates 50% Stake Sale of Opella with CD&R

Sanofi  announces that the company has entered into negotiations with CD&R for the potential sale of a 50% controlling stake in Opella, its cons...

October 11, 2024 | Friday | News
Basilea Pharmaceutica Secures $1.25 Million Milestone Payment Following Strong Sales of Cresemba® in Asia Pacific and China

Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and ...

October 10, 2024 | Thursday | News
Aenitis Technologies Secures Major Funding to Transform Bioproduction with Advanced Acoustofluidic Technology

  Aenitis is set to transform the bioproduction industry by addressing the increasing need for scalable, cost-effective, and highly precise cell ...

October 10, 2024 | Thursday | News
Symbiosis Expands with £1.2M Barclays-Financed Acquisition of New 20,000 Sq/Ft Stirling Facility to Boost High-Tech Medicine Production

    Symbiosis acquires a 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity, financed by £1...

October 09, 2024 | Wednesday | News
Regor Sells Next-Gen CDK Inhibitors to Genentech in $850 Million Deal

Genentech will acquire Regor's next-generation CDK inhibitors for an upfront payment of $850 million in cash. Regor ...

October 07, 2024 | Monday | News
A*STAR and Flagship Pioneering Partner to Drive Breakthrough Innovation in Health and Sustainability with SGD100 Million Investment

Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Acceler...

October 03, 2024 | Thursday | News
Enara Bio Secures $32.5 Million in Series B Financing, Co-Led by Pfizer Ventures and M Ventures

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapi...

October 03, 2024 | Thursday | News
MSD Acquires CN201 from Curon Biopharmaceutical, Advancing B-cell Disease Treatments

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the completion of the acquisition of CN201 from Curon Biopharmaceutical ...

October 02, 2024 | Wednesday | News
Emmes Secures Major NIH Contract to Lead Clinical Coordinating Center for National Institute on Drug Abuse Trials

Emmes, part of Emmes Group, announced they will provide a Clinical Coordinating Center for the NIH's National Institute on Drug Abuse Clinical Trials &nbs...

September 26, 2024 | Thursday | News
Singular Genomics Receives $12.00 Per Share Acquisition Proposal from Concentra Biosciences

Singular Genomics Systems, a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and cli...

September 20, 2024 | Friday | News
Nuance Pharma Expands Bentrio® Nasal Spray Reach Across East and South East Asia

Altamira Therapeutics announces the extension of its exclusive license with Nuance Pharma to cover Singapore, Malaysia, Thailand, Philippines, Indonesia,...

September 17, 2024 | Tuesday | News
Zydus Lifesciences Enters Exclusive Licensing Deal with Viwit Pharmaceuticals for US Launch of Generic MRI Contrast Agents

Zydus Lifesciences Ltd., a global innovation driven healthcare company announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE has...

September 13, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close